LAUSANNE, Switzerland -Thursday 28 June 2018 [ AETOS Wire ] Parallax Development Corp. (“Parallax”) and Philip Morris International (“PMI”) will join forces to develop innovations in alternative nicotine-delivery platforms. Parallax is a start-up co-founded by two leading Canadian pulmonary physicians focused on developing an inhalable nicotine product to provide less harmful alternatives to people who smoke. PMI’s stated ambition is that one out of three of its current consumers — that’s 40 million men and women who currently smoke — will switch to its better alternatives by 2025. (BUSINESS WIRE)-- Philip Morris International Inc. (NYSE: PM) takes another step towards a smoke-free future through a strategic collaboration with Parallax, a Canadian-based start-up. The agreement focuses on advancing the development and commercialization of an effective nicotine-delivery system that leverages the most advanced technologies in pulmonary medicine. This press release features multimedia. V ... Read more »